PTJ
ABBV icon

Paul Tudor Jones’s AbbVie ABBV Stock Holding History

Paul Tudor Jones’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.2M Buy
132,000
+96,900
+276% +$20.8M 0.05% 303
2026
Q1 		$7.63M Sell
35,100
-8,600
-20% -$1.91M 0.01% 903
2025
Q4 		$9.99M Sell
43,700
-163,200
-79% -$37.2M 0.02% 743
2025
Q3 		$47.9M Buy
206,900
+33,200
+19% +$6.76M 0.08% 183
2025
Q2 		$32.2M Buy
+173,700
New +$32.3M 0.07% 212
2025
Q1 		– Sell
-23,300
Closed -$4.14M – 2978
2024
Q4 		$4.14M Buy
23,300
+3,700
+19% +$680K 0.02% 803
2024
Q3 		$3.87M Sell
19,600
-5,800
-23% -$1.08M 0.01% 839
2024
Q2 		$4.36M Sell
25,400
-56,900
-69% -$9.43M 0.02% 711
2024
Q1 		$15M Buy
82,300
+4,600
+6% +$793K 0.1% 222
2023
Q4 		$12M Buy
77,700
+75,600
+3,600% +$11M 0.1% 286
2023
Q3 		$313K Buy
+2,100
New +$308K ﹤0.01% 1909

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paul Tudor Jones's ABBV Position: Q2 2026 in Review

Paul Tudor Jones sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 161,053 shares — an estimated $34.6M sold.

Paul Tudor Jones first reported a position in ABBV in Q2 2013 and held it in 34 quarters. The position peaked at $61.4M in Q2 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Paul Tudor Jones reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 161,053 AbbVie shares in Q2 2026, an estimated $34.6M.
  • Paul Tudor Jones first reported a position in AbbVie in Q2 2013 and held it in 34 quarters.
  • Paul Tudor Jones's AbbVie position peaked at $61.4M in Q2 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.